Aldosterone synthase gene polymorphism, stroke volume and age-related changes in aortic pulse wave velocity in subjects with hypertension
暂无分享,去创建一个
M. Safar | N. de Luca | A. Benetos | P. Lacolley | C. Labat | M. Lajemi | V. Cattan | R. Nzietchueng | N. De Luca | M. Lajémi
[1] J. Staessen,et al. Association of peripheral and central arterial wave reflections with the CYP11B2 –344C allele and sodium excretion , 2004, Journal of hypertension.
[2] M. Safar,et al. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects , 2004, Journal of hypertension.
[3] D. Hayoz,et al. Confounding effects of heart rate on pulse wave velocity in paced patients with a low degree of atherosclerosis. , 2004, Journal of hypertension.
[4] M. Safar,et al. Angiotensin-Converting Enzyme D/I Gene Polymorphism and Age-Related Changes in Pulse Pressure in Subjects with Hypertension , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[5] J. Connell,et al. Is altered adrenal steroid biosynthesis a key intermediate phenotype in hypertension? , 2003, Hypertension.
[6] M. Safar,et al. Increased Carotid Wall Elastic Modulus and Fibronectin in Aldosterone-Salt–Treated Rats: Effects of Eplerenone , 2002, Circulation.
[7] Kathryn Bean,et al. Determinants of Accelerated Progression of Arterial Stiffness in Normotensive Subjects and in Treated Hypertensive Subjects Over a 6-Year Period , 2002, Circulation.
[8] Y. Nikitin,et al. European Project on Genes in Hypertension , 2002 .
[9] P Albaladejo,et al. Heart Rate, Arterial Stiffness, and Wave Reflections in Paced Patients , 2001, Hypertension.
[10] M E Safar,et al. Improvement in Blood Pressure, Arterial Stiffness and Wave Reflections With a Very-Low-Dose Perindopril/Indapamide Combination in Hypertensive Patient: A Comparison With Atenolol , 2001, Hypertension.
[11] F. Cambien,et al. Angiotensin II type 1 receptor−153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects , 2001, Journal of hypertension.
[12] M. Safar,et al. Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats. , 2001, Journal of the American College of Cardiology.
[13] M. Safar. Pulse pressure, arterial stiffness, and cardiovascular risk. , 2000, Current opinion in cardiology.
[14] H. Huikuri,et al. Baroreflex sensitivity and variants of the renin angiotensin system genes. , 2000, Journal of the American College of Cardiology.
[15] S. Rosenfeld,et al. Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction. , 1999, Circulation.
[16] C. Hengstenberg,et al. Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure. , 1999, Circulation.
[17] P. White,et al. Aldosterone synthase (CYP11B2) polymorphisms and cardiovascular function , 1999, The Journal of Steroid Biochemistry and Molecular Biology.
[18] F. Luft,et al. Molecular genetics of human hypertension. , 1998, Current opinion in cardiology.
[19] J. Cohn,et al. Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients. , 1998, European heart journal.
[20] F. Cambien,et al. Genetic determination of plasma aldosterone levels in essential hypertension. , 1998, American journal of hypertension.
[21] R. Carretta. McDonaldʼs Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles , 1998 .
[22] C. Delcayre,et al. Myocardial Production of Aldosterone and Corticosterone in the Rat , 1998, The Journal of Biological Chemistry.
[23] P. White,et al. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. , 1998, Circulation.
[24] J. Blacher,et al. Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. , 1997, American journal of hypertension.
[25] D. Levy,et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. , 1997, Circulation.
[26] M. Safar,et al. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[27] J. Funder. Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance. , 1997, Annual review of medicine.
[28] I. Miyamori,et al. Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin. , 1996, The Journal of clinical endocrinology and metabolism.
[29] 畠山 治彦. Vascular aldosterone : biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells , 1995 .
[30] W. Wang,et al. Chronic administration of aldosterone depresses baroreceptor reflex function in the dog. , 1994, Hypertension.
[31] R. Dilley,et al. Mineralocorticoids, hypertension, and cardiac fibrosis. , 1994, The Journal of clinical investigation.
[32] K. Weber,et al. Myocardial fibrosis: role of angiotensin II and aldosterone. , 1993, Basic research in cardiology.
[33] S. Daniels,et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. , 1992, Journal of the American College of Cardiology.
[34] E. Baulieu,et al. Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. , 1992, Circulation research.
[35] T. Brewer. ARTERIAL PRESSURE AND HYPERTENSION , 1981 .
[36] M. Safar,et al. Relationship of plasma renin activity and aldosterone levels with hemodynamic functions in essential hypertension. , 1977, Archives of internal medicine.